Talk:FOLFIRI

News
FDA Grants New Indication for Cyramza for Metastatic Colorectal Cancer could be mentioned - eg can now have ramucirumab added. Says the FOLFIRI-only arm had PFS of 4.5 months, and median overall survival of 11.7 months. - Rod57 (talk) 08:10, 13 May 2015 (UTC)

Needs a History section
How and when was it developed ? How widely used is it ? eg in USA, Canada, EU, Australia ? - Rod57 (talk) 08:18, 13 May 2015 (UTC)